Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy TCS, Siemens, Reliance Infra; sell Sun Pharma: Sukhani

      Sudarshan Sukhani of s2analytics.com suggests buying TCS, Siemens and Reliance Infra and advises selling Sun Pharma and Castrol India.

    • Buy, sell, hold: 8 stocks that analysts are watching out

      With maintaining buy rating on Motherson Sumi with a target price of Rs 356, UBS says it is a multi-year story and expects 24 percent EPS CAGR over FY16-19 period.

    • Buy TVS Motor, Tata Comm; sell pharma stocks on rally: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy TVS Motor and Tata Communications and sell pharma stocks including Aurobindo Pharma, Sun Pharma and Lupin on rallies.

    • Buy TCS, Granules India; sell Sun Pharma, Dr Reddy's: Thacker

      Mitesh Thacker of miteshthacker.com recommends buying TCS and Granules India and advises selling Sun Pharma and Dr Reddy's Labs.

    • Here's why SP Tulsian is not upbeat on Nalco, Sun Pharma

      SP Tulsian of sptulsian.com in an interview to CNBC-TV18 shares his rationale for not being positive on Nalco and Sun Pharma.

    • Exit Sun Pharma below Rs 640, says Rajat Bose

      Rajat Bose of rajatkbose.com suggests exiting Sun Pharma if the stock breaches Rs 640.

    • Exit Sun Pharma, advises Avinnash Gorakssakar

      Avinnash Gorakssakar, Market Expert is of the view that one may exit Sun Pharmaceutical Industries with a short term view while one may hold the stock with a longer term view.

    • Sell Sun Pharma; buy Ceat: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can sell Sun Pharma and buy Ceat.

    • Sell Sun Pharma, IOC; buy Cholamandalam Investment: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can sell Sun Pharma and Indian Oil Corporation and buy Cholamandalam Investment.

    • Sell Sun Pharma, Apollo Hospitals looks weak: Rajat Bose

      Rajat Bose of rajatkbose.com recommends selling Sun Pharma and feels that Apollo Hospitals looks weak.

    • Buy Sun Pharma, Strides Shasun for long term: Deepak Shenoy

      Deepak Shenoy of capitalmind.in is of the view that pharma stocks like Strides Shasun and Sun Pharma are great stocks to own for a longer term.

    • Buy, sell, hold: 11 key stocks that analysts are watching out

      Credit Suisse has cut target price of Coal India to Rs 370 from Rs 385 per share as it sees little downside to the stock. The company reported very weak Q2 results on account of higher costs across heads. Higher costs pull down FY17-19 EPS by 7-20 percent.

    • Six in Sixty: Stocks you should keep on your radar

      CNBC-TV18's Ekta Batra lists out stocks that you should focus on – TCS, Sun Pharma, Coal India, ITC, Bajaj Auto.

    • Sell Sun Pharmaceutical Industries: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Sun Pharmaceutical Industries.

    • Tulsian upbeat on Motherson Sumi, Bharat Forge, Crompton

      SP Tulsian of sptulsian.com shares his rationale behind his bullish view on Crompton Greaves, Motherson Sumi and Bharat Forge.

    • Buy Eicher Motors, Adani Ports, HDFC, Hero Moto: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Eicher Motors, Adani Ports, HDFC and Hero Motocorp.

    • Sell Shriram Transport, Sun Pharma, Cadila Health: Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Shriram Transport Finance, Sun Pharma and Cadila Healthcare.

    • Sell Sun Pharma; buy HPCL, Century Textiles: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling Sun Pharma and advises buying HPCL and Century Textiles and Industries.

    • Buy Karnataka Bank, Tata Steel, Sun Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Karnataka Bank, Tata Steel and Sun Pharma.

    • Six in Sixty: Stocks you should keep on your radar

      CNBC-TV18's Ekta Batra lists out stocks to focus on – HDFC, Lupin, Sun Pharma, HUL, Tata Steel, Adani Enterprises.

    • Bull's Eye: Buy NIIT Tech, Apollo Tyres, REC, Karnataka Bank

      Shahina Mukadam of Equityrush advises buying NIIT Technologies with a target of Rs 450.

    • Buy L&T, Sun Pharma: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one may buy Larsen and Toubro and Sun Pharma.

    • Buy, sell, hold: 6 stocks to boost your portfolio

      Kotak retains buy rating on Maruti with target cut to Rs 5900 from Rs 6600 per share as demonetisation of currency will impact near-term demand.

    • Here's what Mayuresh Joshi has to say about banks

      In an interview to CNBC-TV18, Mayuresh Joshi of Angel Broking shared his readings and outlook on specific stocks and sectors.

    • Buy, sell, hold: 11 stocks for your portfolio

      Macquarie says Sun Pharma remains its preferred large-cap pharma pick, as it considers it best positioned to make the speciality transition which is essential for long-term growth.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347